Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philip L. Johnson is active.

Publication


Featured researches published by Philip L. Johnson.


Nature Medicine | 2010

A key role for orexin in panic anxiety

Philip L. Johnson; William A. Truitt; Stephanie D. Fitz; Pamela Minick; Amy D. Dietrich; Sonal P. Sanghani; Lil Träskman-Bendz; Andrew W. Goddard; Lena Brundin; Anantha Shekhar

Panic disorder is a severe anxiety disorder with recurrent, debilitating panic attacks. In individuals with panic disorder there is evidence of decreased central γ-aminobutyric acid (GABA) activity as well as marked increases in autonomic and respiratory responses after intravenous infusions of hypertonic sodium lactate. In a rat model of panic disorder, chronic inhibition of GABA synthesis in the dorsomedial-perifornical hypothalamus of rats produces anxiety-like states and a similar vulnerability to sodium lactate–induced cardioexcitatory responses. The dorsomedial-perifornical hypothalamus is enriched in neurons containing orexin (ORX, also known as hypocretin), which have a crucial role in arousal, vigilance and central autonomic mobilization, all of which are key components of panic. Here we show that activation of ORX-synthesizing neurons is necessary for developing a panic-prone state in the rat panic model, and either silencing of the hypothalamic gene encoding ORX (Hcrt) with RNAi or systemic ORX-1 receptor antagonists blocks the panic responses. Moreover, we show that human subjects with panic anxiety have elevated levels of ORX in the cerebrospinal fluid compared to subjects without panic anxiety. Taken together, our results suggest that the ORX system may be involved in the pathophysiology of panic anxiety and that ORX antagonists constitute a potential new treatment strategy for panic disorder.


Animal | 2016

Evaluation of Low versus High Volume per Minute Displacement CO2 Methods of Euthanasia in the Induction and Duration of Panic-Associated Behavior and Physiology

Debra L. Hickman; Stephanie D. Fitz; Cristian Bernabe; Izabela Facco Caliman; Melissa M. Haulcomb; Lauren M. Federici; Anantha Shekhar; Philip L. Johnson

Simple Summary Current recommendations for the use of CO2 as a euthanasia agent for rats require the use of gradual fill methods in order to render the animal insensible prior to their experience of pain. However, there is concern that the use of these gradual fill methods may increase the distress experienced by these animals. We evaluated social and anxiety behavior of rats that had been exposed to concentrations of CO2 that did not cause a loss of consciousness. We also evaluated the physiologic changes of rats that were euthanized with gradual fill protocols as compared to rapid fill methods. We found that rats exposed to concentrations of CO2 that did not cause a loss of consciousness did exhibit increased anxiety and decreased social behavior. We also found that the use of a 10% volume per minute displacement rate of CO2 resulted in physiologic and behavioral changes suggestive of distress. Abstract Current recommendations for the use of CO2 as a euthanasia agent for rats require the use of gradual fill protocols (such as 10% to 30% volume displacement per minute) in order to render the animal insensible prior to exposure to levels of CO2 that are associated with pain. However, exposing rats to CO2, concentrations as low as 7% CO2 are reported to cause distress and 10%–20% CO2 induces panic-associated behavior and physiology, but loss of consciousness does not occur until CO2 concentrations are at least 40%. This suggests that the use of the currently recommended low flow volume per minute displacement rates create a situation where rats are exposed to concentrations of CO2 that induce anxiety, panic, and distress for prolonged periods of time. This study first characterized the response of male rats exposed to normoxic 20% CO2 for a prolonged period of time as compared to room air controls. It demonstrated that rats exposed to this experimental condition displayed clinical signs consistent with significantly increased panic-associated behavior and physiology during CO2 exposure. When atmospheric air was then again delivered, there was a robust increase in respiration rate that coincided with rats moving to the air intake. The rats exposed to CO2 also displayed behaviors consistent with increased anxiety in the behavioral testing that followed the exposure. Next, this study assessed the behavioral and physiologic responses of rats that were euthanized with 100% CO2 infused at 10%, 30%, or 100% volume per minute displacement rates. Analysis of the concentrations of CO2 and oxygen in the euthanasia chamber and the behavioral responses of the rats suggest that the use of the very low flow volume per minute displacement rate (10%) may prolong the duration of panicogenic ranges of ambient CO2, while the use of the higher flow volume per minute displacement rate (100%) increases agitation. Therefore, of the volume displacement per minute rates evaluated, this study suggests that 30% minimizes the potential pain and distress experienced by the animal.


PMC | 2016

Anxiogenic CO2 Stimulus Elicits Exacerbated Hot Flash-like Responses in a Rat Menopause Model and Hot Flashes in Menopausal Women

Lauren M. Federici; Sarah Dorsey Roth; Connie Krier; Stephanie D. Fitz; Todd C. Skaar; Anantha Shekhar; Janet S. Carpenter; Philip L. Johnson


Author | 2018

Role of medial hypothalamic orexin system in panic, phobia and hypertension

Aline Rezende Abreu; Andrei I. Molosh; Philip L. Johnson; Anantha Shekhar


PMC | 2016

Evaluation of Low versus High Volume per Minute Displacement CO₂ Methods of Euthanasia in the Induction and Duration of Panic-Associated Behavior and Physiology

Debra L. Hickman; Stephanie D. Fitz; Cristian Bernabe; Izabela Facco Caliman; Melissa M. Haulcomb; Lauren M. Federici; Anatatha Shekhar; Philip L. Johnson


PMC | 2016

Hypothalamic orexin’s role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model

Lauren M. Federici; Izabela Facco Caliman; Andrei I. Molosh; Stephanie D. Fitz; William A. Truitt; Pascal Bonaventure; Janet S. Carpenter; Anantha Shekhar; Philip L. Johnson


PMC | 2015

OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES

Philip L. Johnson; Lauren M. Federici; Stephanie D. Fitz; John J. Renger; Brock T. Shireman; Christopher J. Winrow; Pascal Bonaventure; Anantha Shekhar


PMC | 2013

Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable rats

Philip L. Johnson; Stephanie D. Fitz; Eric A. Engleman; Kjell Svensson; Jeffrey M. Schkeryantz; Anantha Shekhar


Investigative Ophthalmology & Visual Science | 2013

A Potential Role for the Hypothalamic Orexin System in Mediating Intraocular Pressure Fluctuations

Brian C. Samuels; Nathan M. Hammes; Philip L. Johnson; Anantha Shekhar


Archive | 2012

A NOVEL APPROACH TO MODELING MENOPAUSAL SYMPTOMS AND THE ROLE OF THE OREXIN SYSTEM

Lauren M. Federici; Stephanie D. Fitz; Winter Snow; Todd C. Skaar; Janet S. Carpenter; Anantha Shekhar; Philip L. Johnson

Collaboration


Dive into the Philip L. Johnson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anantha Shekhar

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge